119866 Apr 2026

"119866" appears in Snohomish County PDS Online Records as a permit number for a closed complaint investigation (Permit 23 119866 CT ).

Targeted as a breakthrough therapy for skin conditions. 2. International Health (UNHCR Document 119866) 119866

This is the Investigational New Drug (IND) number for , an interleukin-13 receptor antagonist developed by Dermira Inc. (and later Eli Lilly) for treating moderate-to-severe atopic dermatitis. "119866" appears in Snohomish County PDS Online Records

Progressed through clinical trials, eventually leading to the FDA-approved product Ebglyss . International Health (UNHCR Document 119866) This is the

It details findings regarding health services and community consultations for refugees, specifically in the Jordan region. 3. Commercial Real Estate & Market Research

A major 119,866-square-foot industrial facility was recently acquired by Chemplast , as reported by Colliers International.

The identifier is associated with several distinct official reports and professional records across different sectors. To provide the most helpful summary, please specify which of the following areas you are researching: 1. Pharmaceutical Research (FDA IND 119866)

"119866" appears in Snohomish County PDS Online Records as a permit number for a closed complaint investigation (Permit 23 119866 CT ).

Targeted as a breakthrough therapy for skin conditions. 2. International Health (UNHCR Document 119866)

This is the Investigational New Drug (IND) number for , an interleukin-13 receptor antagonist developed by Dermira Inc. (and later Eli Lilly) for treating moderate-to-severe atopic dermatitis.

Progressed through clinical trials, eventually leading to the FDA-approved product Ebglyss .

It details findings regarding health services and community consultations for refugees, specifically in the Jordan region. 3. Commercial Real Estate & Market Research

A major 119,866-square-foot industrial facility was recently acquired by Chemplast , as reported by Colliers International.

The identifier is associated with several distinct official reports and professional records across different sectors. To provide the most helpful summary, please specify which of the following areas you are researching: 1. Pharmaceutical Research (FDA IND 119866)